Orpea S.A. (ORPEF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Orpea S.A. (ORPEF) trades at $14.22. Orpea S. A. is a leading provider of healthcare services, specializing in nursing homes and rehabilitation facilities across multiple countries. Market cap: $2.29B, Sector: Healthcare.
Price as of Aug 20, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for ORPEF: ORPEF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ORPEF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ORPEF: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Orpea S.A. (ORPEF) Healthcare & Pipeline Overview
Orpea S.A. operates a comprehensive network of nursing homes, assisted-living facilities, and rehabilitation hospitals, delivering personalized healthcare services across Europe and beyond, with a focus on quality care and patient support.
What Is the Investment Thesis for ORPEF?
Orpea S.A. presents a unique investment thesis driven by its extensive network of healthcare facilities and diverse service offerings. With a market capitalization of $2.29B and a presence in over 15 countries, the company is well-positioned to capitalize on the growing demand for elderly care and rehabilitation services, particularly as the global population ages. Despite current financial challenges reflected in a negative P/E ratio of -4.62 and a profit margin of -5.1%, the company’s focus on expanding its home care services and rehabilitation facilities may drive future revenue growth. The ongoing trends towards personalized healthcare and aging population demographics are expected to bolster demand for Orpea’s services. However, investors should remain cautious of potential risks, including regulatory changes and market competition, that could impact profitability in the near term.
Based on FMP financials and quantitative analysis
ORPEF Key Highlights
Market Cap of $2.29B reflects Orpea S.A.'s significant presence in the healthcare sector.
- P/E ratio of -4.62 indicates current financial challenges amidst operational expansion.
- Profit margin of -5.1% highlights the need for operational efficiencies.
- Gross margin of 2.2% suggests limited pricing power in a competitive market.
- Beta of 0.53 indicates lower volatility compared to the broader market.
Who Are ORPEF's Competitors?
ORPEF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AONC American Oncology Network, Inc. | $11.12 | +0.00% | $325M | 50 |
| BHCCF Benchmark Holdings plc | $0.37 | +0.00% | $225M | 41 |
| BRSYF BrainsWay Ltd. | $15.13 | +0.00% | $607M | 62 |
| MFCSF Medical Facilities Corporation | $11.33 | +0.89% | $199M | 47 |
| ADUS Addus HomeCare Corporation | $120.02 | +1.60% | $2.24B | 92 |
| EXETF Extendicare Inc. | $22.83 | +0.00% | $2.16B | 54 |
| MD Pediatrix Medical Group, Inc. | $26.22 | -1.28% | $2.15B | 89 |
| SEM Select Medical Holdings Corporation | $16.51 | -0.09% | $2.05B | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ORPEF's Key Strengths?
Strong market presence in multiple countries enhances brand visibility.
- Comprehensive range of services meets diverse patient needs.
- Experienced management team with a proven track record in healthcare.
What Are ORPEF's Weaknesses?
Negative profit margins indicate financial challenges.
- Dependence on government funding and insurance reimbursements can impact revenue stability.
- Limited pricing power in a competitive market.
What Could Drive ORPEF Stock Higher?
Expansion into emerging markets such as Brazil and China.
- Development of specialized rehabilitation programs to meet growing demand.
- Integration of technology in service delivery to enhance patient care.
What Are the Key Risks for ORPEF?
Financial-distress signal — its Altman Z-Score of 0.83 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-19.9%) — the business is not currently generating profit on shareholder capital.
- Regulatory changes impacting operational costs and funding.
- Intense competition from other healthcare providers affecting market share.
- Economic downturns reducing funding for healthcare services.
What Are the Growth Opportunities for ORPEF?
- Expansion into Emerging Markets: Orpea S.A. is poised to capitalize on the growing demand for healthcare services in emerging markets such as Brazil and China. With a projected CAGR of 8% in the healthcare sector in these regions, Orpea's established presence can leverage local partnerships to enhance service delivery and market penetration.
- Increase in Home Care Services: The global home care market is expected to reach $515 billion by 2027, growing at a CAGR of 8.5%. Orpea's expansion into home care services, including housekeeping and daily life assistance, aligns with the increasing preference for at-home care among aging populations, providing a significant growth avenue.
- Technological Integration in Healthcare: The integration of technology in healthcare services is transforming patient care. Orpea can invest in telemedicine and digital health solutions to improve patient monitoring and engagement, enhancing service efficiency and patient satisfaction.
- Development of Specialized Rehabilitation Programs: With the rise in chronic diseases, there is a growing need for specialized rehabilitation services. Orpea can develop targeted programs for conditions such as stroke recovery and orthopedic rehabilitation, tapping into a market projected to grow at a CAGR of 6.5% over the next five years.
- Partnerships with Healthcare Providers: Collaborating with hospitals and healthcare networks can enhance Orpea's referral systems and patient acquisition. By forming strategic alliances, Orpea can increase its patient base and improve service offerings, driving revenue growth in the long term.
What Are ORPEF's Competitive Advantages?
- Established brand reputation in the healthcare sector across multiple countries.
- Diverse service offerings catering to a wide range of healthcare needs.
- Strong network of facilities providing comprehensive care options.
- Experience in managing complex healthcare operations across various regions.
What Does ORPEF Do?
Founded in 1989 and headquartered in Puteaux, France, Orpea S.A. has established itself as a prominent player in the healthcare sector, specializing in the operation of nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. The company’s nursing homes provide a range of personalized support services, including accommodation, meals, and laundry, along with various daily activities and therapeutic workshops designed to enhance the quality of life for residents. Orpea’s post-acute and rehabilitation hospitals cater to patients with a variety of medical conditions, including geriatrics, musculoskeletal disorders, and oncology, while its psychiatric hospitals address a wide spectrum of mental health issues, from mood disorders to post-traumatic stress disorder. Additionally, Orpea offers home care services that include housekeeping and daily life assistance, allowing for a more personalized approach to patient care. With operations spanning across multiple countries, including France, Belgium, Spain, Italy, and Brazil, Orpea has built a diverse geographic footprint, positioning itself as a leader in the healthcare industry. The company’s commitment to quality care and comprehensive service offerings has enabled it to maintain a significant presence in the competitive healthcare landscape.
What Products and Services Does ORPEF Offer?
- Operate nursing homes providing personalized support services.
- Manage assisted-living facilities for elderly care.
- Run post-acute and rehabilitation hospitals for various medical conditions.
- Offer psychiatric hospital services for mental health disorders.
- Provide home care services including housekeeping and daily life assistance.
- Deliver therapeutic workshops and entertainment services to enhance resident quality of life.
How Does ORPEF Make Money?
- Generate revenue through patient care services in nursing homes and hospitals.
- Charge fees for home care services provided to individuals.
- Receive funding from government and insurance reimbursements for healthcare services.
- Offer specialized rehabilitation programs for additional revenue streams.
What Industry Does ORPEF Operate In?
The healthcare industry, particularly the medical care facilities sector, is experiencing robust growth driven by an aging population and increasing demand for specialized care services. The global market for elderly care services is projected to expand significantly, with a CAGR of approximately 7% over the next five years. Orpea S.A. operates in a competitive landscape alongside peers such as AONC, BHCCF, and BRSYF, all of which are vying for market share in the growing demand for nursing and rehabilitation services. The company's diverse service offerings and geographic reach position it favorably within this expanding market, although it must navigate challenges from regulatory pressures and evolving consumer preferences.
Who Are ORPEF's Key Customers?
- Elderly individuals seeking long-term care and rehabilitation services.
- Patients requiring post-acute medical care.
- Individuals needing home care assistance for daily living activities.
- Families looking for psychiatric care for their loved ones.
Company Profile
Orpea S.A. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Puteaux, FR. The company is led by CEO Laurent Guillot. ORPEF has traded publicly since 2012.
Financial Health
Orpea S.A.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.83 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Orpea S.A. stands at -19.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 31.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.59 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -22.1%, the inverse of the P/E and a quick read on earnings relative to price.
ORPEF Valuation & Market Position
With a $2.29B market cap, Orpea S.A. sits in the mid-cap segment of the market.
Forward Outlook
Wall Street analysts project Orpea S.A. revenue of about $6.02B for fiscal 2026, with EPS near $-0.70. The estimate reflects 6 contributing analysts.
ORPEF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider purchases suggest confidence in Orpea's recovery and future performance.
- Community sentiment has shifted positively, with discussions highlighting the company's restructuring efforts.
- Analysts are optimistic about Orpea's potential to improve operational efficiency, enhancing long-term profitability.
- The healthcare sector's resilience during economic fluctuations supports a favorable outlook for Orpea's business model.
Bear Case
- Concerns remain about Orpea's financial stability and the impact of past scandals on its reputation.
- Negative community sentiment persists, with many questioning the effectiveness of the ongoing restructuring process.
- Market perception is cautious, as investors are wary of potential regulatory challenges in the healthcare sector.
- Recent news highlights ongoing litigation risks that could hinder Orpea's recovery efforts.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ORPEF Latest News
No recent news available for ORPEF.
ORPEF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ORPEF.
Price Targets
Wall Street price target analysis for ORPEF.
ORPEF MoonshotScore
What does this score mean?
The MoonshotScore rates ORPEF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Laurent Guillot
CEO
Laurent Guillot has extensive experience in the healthcare sector, having held various leadership roles throughout his career. He holds a degree in healthcare management and has worked in different capacities within the industry, focusing on operational excellence and strategic growth.
Track Record: Under Laurent's leadership, Orpea has expanded its network of facilities significantly and improved operational efficiencies, despite facing market challenges. His strategic focus on enhancing service delivery and patient care has positioned the company for future growth.
ORPEF OTC Market Information
The OTC Other tier includes companies that do not meet the stringent listing requirements of major exchanges like NYSE or NASDAQ. This tier allows for more flexible trading but may involve lower liquidity and higher volatility.
- OTC Tier: OTC Other
- Lower liquidity may result in higher volatility and price fluctuations.
- Limited access to investor information compared to listed companies.
- Regulatory scrutiny may differ, impacting investor confidence.
- Verify financial statements and disclosures.
- Assess the company's operational performance and market position.
- Review management's strategic plans and growth initiatives.
- Evaluate competitive landscape and industry trends.
- Check for any pending legal or regulatory issues.
- Established brand presence in the healthcare sector.
- Comprehensive service offerings and geographic reach.
- Transparent communication of financial performance and strategic goals.
Common Questions About ORPEF (Healthcare)
What does Orpea S.A. do?
Orpea S.A. specializes in providing a range of healthcare services, including nursing homes, assisted-living facilities, rehabilitation hospitals, and psychiatric hospitals. The company focuses on delivering personalized care and support services to elderly individuals and patients with various medical conditions across multiple countries.
What do analysts say about ORPEF stock?
Analysts have mixed views on ORPEF stock, citing the company's current financial challenges reflected in its negative profit margins and P/E ratio. However, they also highlight the potential for growth through expansion into home care services and emerging markets, making it a stock to watch for future developments.
What are the main risks for ORPEF?
Orpea S.A. faces several risks, including potential regulatory changes that could impact operational costs and funding. Additionally, intense competition in the healthcare sector may pressure profit margins, and economic downturns could lead to reduced funding for healthcare services, affecting overall performance.
What are the key factors to evaluate for ORPEF?
Evaluate ORPEF on fundamentals, analyst consensus, and risk factors. Orpea S.A. presents a unique investment thesis driven by its extensive network of healthcare facilities and diverse service offerings. Not financial advice.
How frequently does ORPEF data refresh on this page?
ORPEF's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ORPEF's recent stock price performance?
Orpea S.A. (ORPEF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong market presence in multiple countries enhances brand visibility. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ORPEF overvalued or undervalued right now?
Orpea S.A. (ORPEF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ORPEF before investing?
Before investing in Orpea S.A. (ORPEF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is subject to change based on market conditions and company performance.